BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20001621)

  • 1. The hypercoagulable state in thalassemia intermedia.
    Taher AT; Musallam KM; Inati A
    Hemoglobin; 2009; 33 Suppl 1():S160-9. PubMed ID: 20001621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalassemia and hypercoagulability.
    Taher AT; Otrock ZK; Uthman I; Cappellini MD
    Blood Rev; 2008 Sep; 22(5):283-92. PubMed ID: 18511163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis in thalassemia: why are we so concerned?
    Musallam KM; Taher AT
    Hemoglobin; 2011; 35(5-6):503-10. PubMed ID: 21910599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redefining thalassemia as a hypercoagulable state.
    Cappellini MD; Motta I; Musallam KM; Taher AT
    Ann N Y Acad Sci; 2010 Aug; 1202():231-6. PubMed ID: 20712798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation and splenectomy: an overview.
    Cappellini MD; Grespi E; Cassinerio E; Bignamini D; Fiorelli G
    Ann N Y Acad Sci; 2005; 1054():317-24. PubMed ID: 16339680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalassemia intermedia: revisited.
    Taher A; Isma'eel H; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalassemia and venous thromboembolism.
    Succar J; Musallam KM; Taher AT
    Mediterr J Hematol Infect Dis; 2011; 3(1):e2011025. PubMed ID: 21713079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercoagulable state in five thalassemia intermedia patients.
    Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolic complications in beta-thalassemia: Beyond the horizon.
    Panigrahi I; Agarwal S
    Thromb Res; 2007; 120(6):783-9. PubMed ID: 17346783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercoagulability in non-transfusion-dependent thalassemia.
    Cappellini MD; Musallam KM; Poggiali E; Taher AT
    Blood Rev; 2012 Apr; 26 Suppl 1():S20-3. PubMed ID: 22631037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary approaches to treatment of beta-thalassemia intermedia.
    Taher AT; Musallam KM; Karimi M; Cappellini MD
    Blood Rev; 2012 Apr; 26 Suppl 1():S24-7. PubMed ID: 22631038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer and portal vein status in splenectomized Egyptian β-thalassemia major patients: a prospective single-thalassemia center experience.
    Elalfy MS; Andrawes NG; Sadek AM; Hussein O; Abdou A
    Pediatr Hematol Oncol; 2012 Apr; 29(3):247-53. PubMed ID: 22475301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulopathy in Beta-thalassemia: current understanding and future perspectives.
    Cappellini MD; Musallam KM; Marcon A; Taher AT
    Mediterr J Hematol Infect Dis; 2009 Dec; 1(1):e2009029. PubMed ID: 21415997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intermediate thalassemia: a new condition associated with hypercoagulability].
    Mannucci PM
    Ann Ital Med Int; 2000; 15(3):187-8. PubMed ID: 11059057
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebral thrombosis in patients with β-thalassemia: a systematic review.
    Haghpanah S; Karimi M
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):212-7. PubMed ID: 22322139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic risk in thalassemic patients.
    Moratelli S; De Sanctis V; Gemmati D; Serino ML; Mari R; Gamberini MR; Scapoli GL
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():915-21. PubMed ID: 10091165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on thalassemia: clinical care and complications.
    Cunningham MJ
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):215-27. PubMed ID: 20113904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia.
    Kanavaki I; Makrythanasis P; Lazaropoulou C; Tsironi M; Kattamis A; Rombos I; Papassotiriou I
    Blood Cells Mol Dis; 2009; 43(3):230-4. PubMed ID: 19654073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.
    Singer ST; Kuypers FA; Styles L; Vichinsky EP; Foote D; Rosenfeld H
    Am J Hematol; 2006 Sep; 81(9):670-5. PubMed ID: 16795058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein thrombosis after splenectomy for beta-thalassemia major.
    Al-Hawsawi ZM; Haouimi AS; Hassan RA; Tarawah AM
    Saudi Med J; 2004 Feb; 25(2):225-8. PubMed ID: 14968225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.